Under conditions of clinical instability, the resulting changes in blood composition alter plasma concentrations of unbound tacrolimus, e.g. through differences in erythrocytes concentrations, as mentioned before 39, 68. Anemia, which is often encountered in this period, increases the unbound tacrolimus plasma concentrations, whereas red blood cell transfusions reduce it.